Jerusalem Pharmaceuticals Co. Ltd. reported unaudited earnings results for the nine months ended September 30, 2018. For the period, the company reported sales of USD 25,489,218 as compared to USD 24,608,203 a year ago. Net income after tax was USD 4,196,241 as compared to USD 4,301,803 a year ago. Net Comprehensive Income was USD 2,832,941 against USD 7,122,333 a year ago. Diluted and basic earnings per share were USD 0.234 as compared to USD 0.238 a year ago.